SCHEMBL18448780

SCHEMBL18448780

Nc1ccc(-c2nccnc2OCCc2ccccc2C2CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 8/20 0.35
▸ EP300 Q09472 1/20 0.32
▸ SLC6A2 P23975 2/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ SLC6A3 Q01959 2/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ FFAR2 O15552 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ HTR1A P08908 2/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ ADRA2A P08913 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ THRB P10828 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ ADRA2B P18089 1/20 0.30
▸ ADRA2C P18825 1/20 0.30
▸ ADRA1D P25100 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18448787 0.83 CYP11B1 (0.39) PDE10ACYP11B1CYP11B2RAB9AADRA2A
SCHEMBL18448289 0.77 NPC1 (0.55) PDE10ACYP11B1CYP11B2NPC1RAB9A
SCHEMBL18448779 0.73 ADRA2A (0.48) PDE10ASLC6A2SLC6A4SLC6A3FFAR2
SCHEMBL18448801 0.69 MPO (0.44) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL18447639 0.68 MAOB (0.53) CYP11B1CYP11B2NPC1RAB9ACYP1A2
SCHEMBL18448243 0.68 EP300 (0.44) EP300
SCHEMBL18486017 0.67 PDE10A (0.35) PDE10A
SCHEMBL18448789 0.66 CYP4F2 (0.49) PDE10ACYP1A2CYP2D6CYP2C19
SCHEMBL18447768 0.65 LMNA (0.36) PDE10AGABRA5
SCHEMBL7898238 0.63 HTR1A (0.61) PDE10ASLC6A2SLC6A4SLC6A3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331863-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2018-06-13 — — EP disclosed
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 — — WO disclosed
Send feedback